: Ketamine is an intravenous hypnotic anesthetic that acts primarily by inhibiting N-methyl-D-aspartate (NMDA) receptors, leading to a range of effects, including hypnosis, analgesia, anticonvulsant activity, anti-inflammatory action, and neuroprotection. Initially, there were concerns that ketamine might elevate intracranial pressure. However, these worries have since been dispelled, leading to a renewed consideration of its role in neurocritical care. This evolving understanding has facilitated its increasing use in neurosurgical patients, both in the operating room and intensive care units, where it provides hemodynamic stability and neuroprotective benefits. Additionally, ketamine has shown promise in managing specific neurological conditions such as stroke and refractory seizures, further broadening its clinical applications. This review aims to provide a comprehensive clinical summary of ketamine's usefulness in these settings.

Domi, R., Cani, A., Abdyli, A., Huti, G., Dodaj, S., Coniglione, F., et al. (2025). Ketamine in Neurocritical Care: New Potentials and Perspectives. CUREUS, 17(6) [10.7759/cureus.85456].

Ketamine in Neurocritical Care: New Potentials and Perspectives

Domi, Rudin
Writing – Original Draft Preparation
;
Huti, Gentian
Membro del Collaboration Group
;
Coniglione, Filadelfo
Investigation
;
2025-06-01

Abstract

: Ketamine is an intravenous hypnotic anesthetic that acts primarily by inhibiting N-methyl-D-aspartate (NMDA) receptors, leading to a range of effects, including hypnosis, analgesia, anticonvulsant activity, anti-inflammatory action, and neuroprotection. Initially, there were concerns that ketamine might elevate intracranial pressure. However, these worries have since been dispelled, leading to a renewed consideration of its role in neurocritical care. This evolving understanding has facilitated its increasing use in neurosurgical patients, both in the operating room and intensive care units, where it provides hemodynamic stability and neuroprotective benefits. Additionally, ketamine has shown promise in managing specific neurological conditions such as stroke and refractory seizures, further broadening its clinical applications. This review aims to provide a comprehensive clinical summary of ketamine's usefulness in these settings.
giu-2025
Pubblicato
Rilevanza internazionale
Articolo
Sì, ma tipo non specificato
Settore MED/41
Settore MEDS-23/A - Anestesiologia
English
Con Impact Factor ISI
anticonvulsant
ketamine
neurocritical care
sedation
• neuroprotection
Domi, R., Cani, A., Abdyli, A., Huti, G., Dodaj, S., Coniglione, F., et al. (2025). Ketamine in Neurocritical Care: New Potentials and Perspectives. CUREUS, 17(6) [10.7759/cureus.85456].
Domi, R; Cani, A; Abdyli, A; Huti, G; Dodaj, S; Coniglione, F; Grada, M; Leka, V; Naco, M; Bajraktari, M
Articolo su rivista
File in questo prodotto:
File Dimensione Formato  
unpaywall-bitstream--1903143924.pdf

accesso aperto

Tipologia: Versione Editoriale (PDF)
Licenza: Creative commons
Dimensione 494.97 kB
Formato Adobe PDF
494.97 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2108/460463
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact